State Mushroom Psychedelic Research

The State of Mushroom & Psychedelic Research: June 2026

The big picture. ShroomWire is tracking 1531 studies across mushrooms, psychedelics, and brain-health research, each graded A–F for evidence strength. Here’s where the evidence actually stands this month — including how much is still early-stage, and what’s been retracted.

Evidence strength across everything we track

Most of the field is still early — and we think saying so plainly is the point.

Grade A58 (4%)
Grade B70 (5%)
Grade C565 (37%)
Grade D657 (43%)
Grade E15 (1%)
Grade F166 (11%)

What’s being researched

Psychedelics523 (34%)
Functional mushrooms466 (30%)
Neuroscience271 (18%)
Mycology & materials271 (18%)

Early-signal & integrity watch

  • 239 tracked items are preprints (not yet peer-reviewed) — promising but provisional.
  • 0 are flagged retracted and are never presented as standing evidence.

Most notable studies right now

Methodology: see how we grade the evidence. This is a living snapshot, regenerated regularly from our research database.

## Educational Disclaimer

This article is for informational and educational purposes only. It is not
medical advice, mental health advice, diagnosis, treatment guidance, or a
recommendation to use any substance, supplement, therapy, or protocol.

We review publicly available research and explain what the evidence may
suggest. Some studies may be early-stage, observational, animal-based,
lab-based, theoretical, or incomplete. Always consult a qualified
professional before making health-related decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *